Furthermore, when ACY-241 and PCI-34051 were treated in the mutant p53 ovarian cancer cell, COV362, neither acetyl-p53 (K381) nor acetyl-α-tubulin were synergistically upregulated (Supplementary Figure S2A). This evidence concerns the gene TP53 and ovarian cancer.